EORTC Group Study 30851: a phase II study of neoadjuvant chemotherapy in patients with invasive bladder cancer.
Splinter
T A
TA
University Hospital Dijkzigt, Department of Medical Oncology, The Netherlands.
Jacqmin
D
D
Roberts
J T
JT
Pavone-Macaluso
M
M
de Pauw
M
M
Sylvester
R
R
Carpentier
P
P
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology